Risperidone News and Research

RSS
Braeburn, Camurus announce FDA Fast Track designation for CAM2038 to treat opioid addiction

Braeburn, Camurus announce FDA Fast Track designation for CAM2038 to treat opioid addiction

Lithium can be safe, effective for children suffering from bipolar disorder

Lithium can be safe, effective for children suffering from bipolar disorder

FDA accepts Braeburn's resubmission of Probuphine NDA for review

FDA accepts Braeburn's resubmission of Probuphine NDA for review

Phase III trial results show cariprazine effective in treating negative symptoms associated with schizophrenia

Phase III trial results show cariprazine effective in treating negative symptoms associated with schizophrenia

Medicaid could save billions as patents for several blockbuster antipsychotic medications expire

Medicaid could save billions as patents for several blockbuster antipsychotic medications expire

Use of antipsychotic drugs more common in boys than girls, research shows

Use of antipsychotic drugs more common in boys than girls, research shows

Long-acting injectable antipsychotic medication benefits people with schizophrenia

Long-acting injectable antipsychotic medication benefits people with schizophrenia

Braeburn reports positive topline results from Probuphine Phase 3 study for treatment of opioid addiction

Braeburn reports positive topline results from Probuphine Phase 3 study for treatment of opioid addiction

Indivior reports top-line results from RBP-7000 phase 3 trial for treatment of schizophrenia

Indivior reports top-line results from RBP-7000 phase 3 trial for treatment of schizophrenia

New study explores parent satisfaction with research study on treating severe childhood aggression

New study explores parent satisfaction with research study on treating severe childhood aggression

Study explores use of antipsychotic medications among pediatric patients

Study explores use of antipsychotic medications among pediatric patients

Added benefit of lurasidone drug not proven for schizophrenia

Added benefit of lurasidone drug not proven for schizophrenia

UCLA researchers find new treatment that restores normal social behavior in autism mice model

UCLA researchers find new treatment that restores normal social behavior in autism mice model

Janssen announces submission of NDA for three-month paliperidone palmitate

Janssen announces submission of NDA for three-month paliperidone palmitate

Stimulation therapy and behavioral management training for parents reduce kids’ violent behaviors

Stimulation therapy and behavioral management training for parents reduce kids’ violent behaviors

Antipsychotic medication can reduce violent crime among people with psychiatric illness

Antipsychotic medication can reduce violent crime among people with psychiatric illness

Antipsychotic medication reduces violent crime rates

Antipsychotic medication reduces violent crime rates

More antipsychotic medications prescribed to children and adolescents in Germany

More antipsychotic medications prescribed to children and adolescents in Germany

Study supports use of two drugs for treating children with aggression and disruptive behavior

Study supports use of two drugs for treating children with aggression and disruptive behavior

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets